Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-03 | John T. Henderson, M.B., Ch.B. Class III Audit Committee member Compensation and Talent Committee member Nominating and Governance Committee member 2018 compensation: $287,906 Director Compensation section |
| 2020-03-26 | John T. Henderson, M.B., Ch.B. 75 Class III Audit Committee 22,500 Compensation and Talent Committee 185,644 Nominating and Governance Committee |
| 2022-04-08 | The following table sets forth the names of each member of our Board of Directors, their age, position, director class and committee membership as of April 8, 2022. John T. Henderson, M.B., Ch.B. 77 Chair, Class III Audit Committee Chair Nominating and Governance Committee Science and Technology Committee ... Director Compensation Table for 2021 Dr. Henderson $65,000 $150,781 $121,600 $337,381 |
| 2023-04-07 | The Audit Committee consists of directors Ms. Parshall (Chair), Dr. Kaye, Dr. Henderson and Mr. Smith. The Nominating and Governance Committee consists of directors Dr. Henderson (Chair), Ms. Bhanji, Mr. Costa, and Ms. Parshall. |
| 2024-04-08 | John T. Henderson, M.B., Ch.B. has served as a member of our Board of Directors since February 2009 and as Chairman of our Board of Directors since April 2022. Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm LLC. Dr. Henderson consulted for NeuroVia, Inc. as Chief Development Officer and was an executive officer of this privately held company until October 2018. Until his retirement in December 2000, Dr. Henderson was with Pfizer Inc. for over 25 years, most recently as a Vice President in the Pfizer Pharmaceuticals Group. Dr. Henderson previously held Vice Presidential level positions with Pfizer in Research and Development in Europe and later in Japan. He was also Vice President, Medical for Pfizer’s Europe, U.S. and International Pharmaceuticals groups. Dr. Henderson has served on the Board of Directors of Myriad Genetics, Inc., a healthcare diagnostics company, from 2004 to December 2020, including as Chairman. Dr. Henderson earned his bachelor of science and medical degrees from the University of Edinburgh and is a Fellow of the Royal College of Physicians (Ed.) and the Faculty of Pharmaceutical Medicine. |
Data sourced from SEC filings. Last updated: 2026-03-09